Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Amortization of Deferred Charges (2016 - 2019)

Aethlon Medical (AEMD) has disclosed Amortization of Deferred Charges for 9 consecutive years, with $30287.0 as the latest value for Q1 2019.

  • For the quarter ending Q1 2019, Amortization of Deferred Charges changed 0.0% year-over-year to $30287.0, compared with a TTM value of $121148.0 through Mar 2019, down 50.69%, and an annual FY2020 reading of $30287.0, down 75.0% over the prior year.
  • Amortization of Deferred Charges was $30287.0 for Q1 2019 at Aethlon Medical, roughly flat from $30287.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $156597.0 in Q1 2016 and bottomed at $18998.0 in Q3 2016.
  • Average Amortization of Deferred Charges over 5 years is $73340.4, with a median of $30287.0 recorded in 2017.
  • The sharpest move saw Amortization of Deferred Charges skyrocketed 3221.73% in 2015, then tumbled 85.92% in 2016.
  • Year by year, Amortization of Deferred Charges stood at $134919.0 in 2015, then crashed by 85.92% to $18998.0 in 2016, then soared by 59.42% to $30287.0 in 2017, then changed by 0.0% to $30287.0 in 2018, then changed by 0.0% to $30287.0 in 2019.
  • Business Quant data shows Amortization of Deferred Charges for AEMD at $30287.0 in Q1 2019, $30287.0 in Q4 2018, and $30287.0 in Q3 2018.